← SynDRA
ISRADIPINE
SynDRA canonical compound SYN0016085 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CACNA2D1 |
|---|
| Mechanism of action | Calcium channel blocker |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
- CACNA1C
- CACNA1D
- CACNA1F
- CACNA1S
- CACNA2D1
- CACNA1H
- Cacna1c
- Cacna1d
- Cacna1f
- KCNH2
- NR1I2
Mechanisms of action (all sources)
- Calcium channel blocker
- CACNA1C BLOCKER
- Voltage-gated L-type calcium channel blocker
- CACNA1S BLOCKER
- CACNA1D BLOCKER
- CACNA1F BLOCKER
- CACNA1S ANTAGONIST
- CACNA1C ANTAGONIST
- CACNA1D MODULATOR
- CACNA1F ANTAGONIST
- CACNA1C GATING INHIBITOR
- CACNA1D GATING INHIBITOR
Drug classes
- Calcium Channel Antagonists
- Dihydropyridine Calcium Channel Blocker
- Antihypertensive Agents
- Calcium Channel Blockers
- Calcium-Regulating Hormones and Agents
- Cardiovascular Agents
- Membrane Transport Modulators
- Vasodilator Agents
ATC classes
- C08C · SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
Cross-references
Synonyms
- dynacrine
- isradipin
- isrodipine
- Isradipino
- Isrodipine
- NSC-759892
- PN-200-110
- Dynacirc
- Dynacirc cr
- Prescal
- NSC 759892
- YO1UK1S598
- isradipine (usp-rs)
- DynaCirc
- isradipine (ep monograph)
- isradipine (usp monograph)
- Lomir
- Dynacirc CR
- Isradipinum
- DTXCID203179
- PN 205 033
- PN 205 034
- isradipina
- PN205033
- PN205034
- PN 205033
- PN 205034
- RefChem:56439
- C08CA03
- Isradipin
- Esradin
- Clivoten
- Dynacrine
- Isradipinum [Latin]
- Isradipino [Spanish]
- Rebriden
- DynaCire
- DynaCire CR
Reported adverse events
- Dizziness
- Fatigue
- Flushing
- Headache
- Nausea
- Palpitations
- Pollakiuria
- Rash
- Tachycardia
- Vomiting
Look up ISRADIPINE in the interactive SynDRA portal →